Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Corbus Pharmaceuticals Holdings, Inc.

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Stock Overview

Explore Corbus Pharmaceuticals Holdings, Inc.’s financial performance, market position, analyst ratings, and future outlook.

CRBP●NASDAQ
HealthcareBiotechnology
$7.65
$0.17(2.27%)
U.S. Market opens in NaNh NaNm

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Meyka AI Score

Z

Key Financials

Market Cap141.7M
P/E Ratio-1.17
EPS (TTM)$-6.19
ROE-0.87%
Fundamental Analysis

AI Price Forecasts

1 Month$12.41
3 Months$10.11
1 Year Target$1.73

CRBP Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Corbus Pharmaceuticals Holdings, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CRBP on the NASDAQ shows an RSI of 33.51, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $1.73 for the NASDAQ listing.

Key metrics behind Corbus Pharmaceuticals Holdings, Inc.'s NASDAQ-traded stock include a P/E ratio of -1.17 and a market capitalization of 141.7M. Combined with our AI analysis, these give both institutional and retail investors a clear view of CRBP on the NASDAQ.

Price Performance (NASDAQ: CRBP)

1-Day Change
2.27%
5-Day Change
11.52%
1-Month Change
-26.30%
3-Month Change
-7.94%
6-Month Change
-11.05%
Year-to-Date (YTD) Change
-6.02%
1-Year Change
-33.82%
3-Year Change
17.69%
5-Year Change
-74.75%
All-Time (Max) Change
-91.50%

Contact Information

https://www.corbuspharma.com
617 963 0100
500 River Ridge Drive, Norwood, MA, 02062

Company Facts

360 Employees
IPO DateOct 27, 2014
CountryUS
Actively Trading

Frequently Asked Questions